Tokyo, June 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062030) titled 'Prediction and Assessment of Hepatitis B Virus Reactivation Risk Under Immunosuppressive Therapy' on June 23.
Study Type:
Observational
Primary Sponsor:
Institute - Kyoto University
Condition:
Condition - HBV reactivation
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to develop an artificial intelligence (AI)-based predictive model capable of distinguishing progression to true HBV reactivation from spontaneous viral clearance by training on longitudinal viral load trajectories and clinical outcomes of patients with HBV reactivation who d...